关键信息
-
基因名
CSAD
- 应用
-
别名
PCAP; CSD; P-Selectin Cytoplasmic Tail-Associated Protein; Sulfinoalanine decarboxylase; Cysteine-sulfinate decarboxylase
-
种属
Human
-
表达系统
E. coli
-
标签
N- His & GST
-
纯度
Greater than 95% as determined by SDS-PAGE.
-
蛋白编号
Q9Y600
-
表达区间
Glu234~Leu493
-
分子量
59kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
The study of CSAD (Cysteine Sulfinic Acid Decarboxylase) recombinant protein has gained significant attention due to its critical role in the synthesis of the neurotransmitter taurine, which is essential for various physiological functions, including osmoregulation, neurotransmission, and calcium signaling. CSAD catalyzes the decarboxylation of cysteine sulfinic acid to produce hypotaurine, the immediate precursor of taurine. Dysfunction or deficiency of CSAD has been implicated in several neurological disorders, highlighting the importance of understanding this enzyme's structure, function, and regulation. The use of recombinant DNA technology allows for the production of high quantities of CSAD protein, facilitating detailed biochemical and structural studies. Researchers aim to elucidate the enzyme's mechanism of action, its kinetic properties, and its interaction with other metabolic pathways. Furthermore, insights gained from CSAD studies could lead to the development of therapeutic strategies targeting taurine-related disorders, making it a promising area of research in neurobiology and metabolic science.
